Efficacy of continuous subcutaneous insulin infusion (CSII) in patients with classical contraindications to its use
- PMID: 17976206
- DOI: 10.1111/j.1464-5491.2007.02264.x
Efficacy of continuous subcutaneous insulin infusion (CSII) in patients with classical contraindications to its use
Comment on
-
Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service.Diabet Med. 2005 Jul;22(7):842-9. doi: 10.1111/j.1464-5491.2005.01539.x. Diabet Med. 2005. PMID: 15975097
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
